BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 27070911)

  • 1. Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    DeGruttola AK; Low D; Mizoguchi A; Mizoguchi E
    Inflamm Bowel Dis; 2016 May; 22(5):1137-50. PubMed ID: 27070911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific changes of enteric mycobiota and virome in inflammatory bowel disease.
    Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J
    J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory bowel diseases and enteric microbiota].
    Kim JM
    Korean J Gastroenterol; 2010 Jan; 55(1):4-18. PubMed ID: 20098062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
    Ray A; Dittel BN
    Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal dysbiosis in inflammatory bowel disease.
    Kaur N; Chen CC; Luther J; Kao JY
    Gut Microbes; 2011; 2(4):211-6. PubMed ID: 21983063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?
    Burman S; Hoedt EC; Pottenger S; Mohd-Najman NS; Ó Cuív P; Morrison M
    Dig Dis; 2016; 34(1-2):64-71. PubMed ID: 26982568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.
    Lim JS; Lim MY; Choi Y; Ko G
    Mol Brain; 2017 Apr; 10(1):14. PubMed ID: 28427452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis in intestinal inflammation: Cause or consequence.
    Buttó LF; Haller D
    Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models.
    Mizoguchi E; Low D; Ezaki Y; Okada T
    Intest Res; 2020 Apr; 18(2):151-167. PubMed ID: 32326669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease.
    Qi Y; Zang SQ; Wei J; Yu HC; Yang Z; Wu HM; Kang Y; Tao H; Yang MF; Jin L; Zen K; Wang FY
    Genomics; 2021 Jan; 113(1 Pt 2):664-676. PubMed ID: 33010388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
    Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
    APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
    Shapiro JM; Cho JH; Sands BE; LeLeiko NS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):842-6. PubMed ID: 25725444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.